Integrated Laboratory Systems, LLC (ILS) has been acquired by Inotiv and joins their dynamic team to combine our expertise and comprehensive portfolio of genetic toxicology and other testing services with Inotiv's industry leading nonclinical and analytical drug discovery and development platform. Click the link [...]
Four members of the ILS scientific team are newly minted diplomates of the American Board of Toxicology. Drs. AtLee Watson, PhD, DABT, Christopher Sproul, PhD, Cynthia Willson MS, PhD, DVM, DACVP, DABT, and Debabrata Mahapatra, DVM, MS, PhD, DACVP successfully completed the DABT certification exam which [...]
Principal Toxicologist Neepa Choksi, PhD Accepts the 2021 Ocular Toxicology Specialty Section Paper of the Year Award
Principal Toxicologist Neepa Choksi, PhD accepted the Taylor & Francis 2021 Ocular Toxicology Specialty Section Paper of the Year Award for the manuscript “Validation of the OptiSafe eye irritation test.” Dr. Choksi served as lead author on the paper and highlights work coordinated by her [...]
ILS Chief Scientific Officer Les Recio, PhD, DABT has been awarded a Small Business Innovative Research (SBIR) Grant from the NIEHS for his Phase I application, “Mutational profiling in human cells as an in vitro alternative to in vivo mutagenicity assessments." The focus of this [...]
Members of the ILS Scientific Team present posters during the 2021 Society of Toxicology (SOT) Meeting & ToxExpo. This year's conference is being held virtually March 12-26, 2021. Below is a collection of the ILS staff posters being presented or featured including a link to [...]
ILS scientists help FDA evaluate the genotoxic potential of over 150 electronic nicotine delivery systems (ENDS) flavorings using cell-based and computational methods. More information on the ILS' work with the FDA can be found here.
ILS Toxicologic Pathologist Kristen Hobbie, D.V.M., Ph.D., recently gave an interview to the TPX Podcast to discuss a recent article she wrote entitled: “Evaluation of Cystic Endometrial Hyperplasia and the Normal Estrous Cycle in Longitudinal Sections of Uterus from Female Harlan Sprague-Dawley Rats.”
ILS Toxicology Study Director, Melanie Foster, DABT presented the following poster titled, "So You Want To Do Regulatory Developmental Neurotoxicology Studies: A Training and Validation Plan." The poster was presented at the Society for Birth Defects Research & Prevention virtual meeting on June 29th, 2020 [...]
ILS Director of Toxicology, Cheryl Hobbs, PhD, Study Director/Health and Safety Officer, Michael A. Streicker, LATG, and Analytical Chemistry Study Director, Formulations Manager, Keith Burke co-authored the poster titled, "Absence of in vivo genotoxicity of a purified Aloe vera whole leaf juice concentrate when tested [...]
ILS’ Lead Computational Chemist, Kamel Mansouri, Ph.D., presented a webinar titled, “International computational collaborations for predictive toxicology,” on Tuesday, May 2nd, 2020.